Spire Healthcare Group plc
18 March 2021
Notification of Transactions of Persons Discharging Managerial Responsibilities
This notification is made in accordance with DTR 3.1.4R (1) (a) of the Disclosure and Transparency Rules.
Grant of Deferred Share Bonus Plan (DSBP) Awards
Spire Healthcare Group plc (the Company) announces that on 18 March 2021, awards (the DSBP Awards) were granted over the Company's ordinary shares in the form of nil-cost options to the Directors named below, under the Spire Healthcare Group plc Deferred Share Bonus Plan.
Under the DSBP, Executive Directors are required to defer a proportion of their gross cash bonus, received in respect of the full year ended 31 December 2020, into shares in the Company for a period of three years. The Directors listed below have the following interest in shares as deferred share bonus awards under the DSBP:
| Director | Percentage deferral of 2020 gross cash bonus* | Deferred Shares |
| Justin Ash | 50% | 96,785 |
| Jitesh Sodha | 33% | 41,437 |
* To be disclosed in the 2020 Annual Report and Accounts
The share price used to determine the number of Deferred Shares subject to award was 166.8 pence, being the mid-market closing share price on 17 March 2021 (the dealing day prior to the awards being made).
The DSBP Awards will vest on the third anniversary of the grant date on 18 March 2024, subject to continued employment. Upon vesting, the options will remain exercisable until 17 March 2031.
Grant of 2020 Long Term Incentive Plan (LTIP) awards
The Company further announces that, on 18 March 2021, a performance share award was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Directors and PDMR in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan.
Executive Director Maximum number of shares under Award
Justin Ash 667,314
Jitesh Sodha 448,992
Other PDMRs
John Forrest 232,513
The number of shares set out above represents 175% of each Executive Director's base salary and 100% of John Forrest's base salary. It is the maximum number which may vest under the LTIP Awards following the end of the performance period (31 December 2024). The shareholder-approved Remuneration Policy permits awards of up to 200% of base salary.
The actual number of shares which vest will depend on the extent to which the relevant performance conditions have been satisfied.
The performance conditions applicable to the LTIP Awards will be based as follows:
· 35% on relative total shareholder return (TSR) performance;
· 35% on ROCE performance; and
· 30% on two Operational Excellence measures.
Further details of these performance conditions will be disclosed in the 2020 Annual Report and Accounts when published.
The share price used to determine the number of shares under the LTIP Awards was 163.7 pence being the average of the mid-market closing share price over the five trading days ending on 17 March 2021.
The transaction place is London.
Notes:
1) As previously disclosed, Justin Ash and Jitesh Sodha also have interests in awards granted under the DSBP during 2020. Details of these will be included in the Company's 2020 Annual Report and Accounts.
2) The 2021 LTIP awards described above will also be subject to a further two-year holding period following the vesting date.
3) As previously disclosed, Justin Ash, Jitesh Sodha and John Forrest also have interests in awards granted under the LTIP during 2019 and 2020. Details of these for Justin Ash and Jitesh Sodha will be included in the Company's 2020 Annual Report and Accounts.
4) The actual number of shares which vest will depend on the extent to which the relevant performance conditions are satisfied in due course.
Name of contact and telephone number for queries:
Philip Davies
Company Secretary
Spire Healthcare Group plc
Tel: 07803 508348
The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
|
|
| ||
| a) | Name
| Justin Ash | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Executive Officer/PDMR | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of performance share awards under the Company's Deferred Share Bonus Plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 96,785 | ||
|
| |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2021-03-18 | |
| f) | Place of the transaction | XLON | |
|
|
| ||
| a) | Name
| Jitesh Sodha | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Financial Officer/PDMR | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of performance share awards under the Company's Deferred Share Bonus Plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 41,437 | ||
|
| |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2021-03-18 | |
| f) | Place of the transaction | XLON | |
|
|
| ||
| a) | Name
| Justin Ash | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Executive Officer/PDMR | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of performance share awards under the Company's Long Term Incentive Plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 667,314 | ||
|
| |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2021-03-18 | |
| f) | Place of the transaction | XLON | |
|
|
| ||
| a) | Name
| Jitesh Sodha | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Financial Officer/PDMR | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of performance share awards under the Company's Long Term Incentive Plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 448,992 | ||
|
| |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2021-03-18 | |
| f) | Place of the transaction | XLON | |
| a) | Name
| John Forrest | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Operating Officer/PDMR | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of performance share awards under the Company's Long Term Incentive Plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 232,513 | ||
|
| |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2021-03-18 | |
| f) | Place of the transaction | XLON | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
